Daiichi Sankyo India Pharma Private Limited - Company Profile

It is a media and publishing private limited company based in Gurgaon, Haryana, India, established in 2007.
2007 Gurgaon, Haryana, India Dissolved (Liquidated)
Last Updated:
Access Report
About Daiichi Sankyo India Pharma Private Limited

Daiichi Sankyo India Pharma Private Limited, a dissolved (liquidated) private limited company, was established on 13 March 2007 in Gurgaon, Haryana, India. Engaging in book & digital publishing within the media and publishing sector, it holds CIN: U24233HR2007PTC044362. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹178.00 Cr and a paid-up capital of ₹177.00 Cr.

Employing 9 professional, Its leadership includes Masahiko Otsuki (Director), Takashi Mochizuki (Director), Velloor Venkatakrishnan Ranganathan (Director). Past directors included Yoshiyuki Kobayashi, Kiminori Nagao, Kazunori Hirokawa. Its latest AGM occurred on 28 September 2016, with the balance sheet filed on 31 March 2016. It is based at Unit 62, Level 18, One Horizon Center, Golf Course Road, Dlf Phase 5, Sector-4, 3, Gurgaon, Haryana, 122002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233HR2007PTC044362

  • Registration Number

    044362

  • Incorporation Date

    13 March 2007

  • Authorized Capital

    ₹178.00 Cr

  • Paid-Up Capital

    ₹177.00 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Dissolved (Liquidated)

Key Metrics
  • Authorised Capital ₹ 178.00 Cr
  • Paid Up Capital ₹ 177.00 Cr
  • Company Age 19 Year, 3 Months
  • Last Filing with ROC 31 Mar 2016
  • Revenue Growth **** 3.15%
  • Profit Growth **** 7.27%
  • Ebitda **** -7.13%
  • Net Worth 10.37%
  • Total Assets **** 10.64%
Company report

Daiichi Sankyo India Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Daiichi Sankyo India Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Daiichi Sankyo India Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Masahiko Otsuki Director 12 Aug 2010 Current
Takashi Mochizuki Director 01 Jul 2017 Current
Velloor Venkatakrishnan Ranganathan Director 01 Jul 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2016 Past
Pramod Abcsdd Director 01 Apr 2016 Past
Pramod Abcsdd Director 01 Apr 2012 Past
Pramod Abcsdd Director 29 Jul 2011 Past
Pramod Abcsdd Director 01 Jul 2017 Past
Pramod Abcsdd Additional Director 28 Aug 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daiichi Sankyo India Pharma.

Daiichi Sankyo India Pharma Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 3.15% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth Soared by an impressive increase of 10.37%.

Daiichi Sankyo India Pharma revenue growth over time
Daiichi Sankyo India Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.15%
*******
*******
*******
*******
Revenue from Operations
*******
 2.35%
*******
*******
*******
*******
Total Assets
*******
 10.64%
*******
*******
*******
*******
Profit or Loss
*******
 7.27%
*******
*******
*******
*******
Net Worth
*******
 10.37%
*******
*******
*******
*******
EBITDA
*******
 -7.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daiichi Sankyo India Pharma?

In 2016, Daiichi Sankyo India Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Daiichi Sankyo India Pharma?

Unlock and access historical data on people associated with Daiichi Sankyo India Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daiichi Sankyo India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daiichi Sankyo India Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daiichi Sankyo India Pharma
Recent Activity within the Organization
  • Director Appointment

    Takashi Mochizuki was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 9 years 2 days . was recorded as a recent event.

  • Director Appointment

    Progress on Velloor Venkatakrishnan Ranganathan was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 9 years 2 days . was documented.

  • Annual General Meeting

    Progress on Daiichi Sankyo India Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2016 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Daiichi Sankyo India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi. was completed.

  • Director Appointment

    Masahiko Otsuki was appointed as a Director was appointed as a Director on 12 Aug 2010 & has been associated with this company since 15 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Daiichi Sankyo India Pharma Private Limited was registered on 13 Mar 2007 with Roc Delhi & aged 19 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daiichi Sankyo India Pharma Private Limited?

The CIN of Daiichi Sankyo India Pharma Private Limited is U24233HR2007PTC044362.

Where is Daiichi Sankyo India Pharma Private Limited headquartered?

Daiichi Sankyo India Pharma Private Limited is headquartered at Unit 62, Level 18, One Horizon Center, Golf Course Road, Dlf Phase 5, Sector-4, 3, Gurgaon, Haryana, 122002.

When was Daiichi Sankyo India Pharma Private Limited incorporated?

Daiichi Sankyo India Pharma Private Limited was incorporated on 13 March 2007.

Who are the current directors of Daiichi Sankyo India Pharma Private Limited?

The current directors of Daiichi Sankyo India Pharma Private Limited are

What is the primary industry of Daiichi Sankyo India Pharma Private Limited?

The primary industry of Daiichi Sankyo India Pharma Private Limited is Media And Publishing.

Is Daiichi Sankyo India Pharma Private Limited a listed company?

Daiichi Sankyo India Pharma Private Limited is unlisted.

What is the capital structure of Daiichi Sankyo India Pharma Private Limited?

The authorized capital of Daiichi Sankyo India Pharma Private Limited is ₹178.00 Cr, and the paid-up capital is ₹177.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available